A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand
Launched by RESEARCH SOURCE · Oct 25, 2022
Trial Information
Current as of July 04, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a prospective, post-market, observational, single center study evaluating the use of VersaWrap. Patients identified by the Investigator in his practice as needing surgery of the hand/fingers and meeting all the inclusion and none of the exclusion. Patients will consent to participating in the study, prior to any study procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients aged 18-70 at the time of surgery
- • 2. Patients undergoing hand/finger surgery, including tendon repair, fracture repair or tenolysis
- • 3. Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule, study requirements with a signed informed consent with a study collaborator present at the time of signing to ensure compliance.
- Exclusion Criteria:
- • 1. Non-English speaking
- • 2. Known allergy or sensitivity to citrate, alginate or hyaluronate
- • 3. Pregnant or breastfeeding
- • 4. Currently a prisoner
- • 5. Patient has any condition, that in the opinion of the Investigator, would prohibit the patient from complying with the protocol
About Research Source
Research Source is a leading clinical trial sponsor dedicated to advancing medical science through innovative research and development. With a focus on delivering high-quality, evidence-based solutions, Research Source collaborates with a diverse network of healthcare professionals, institutions, and industry partners to conduct rigorous clinical studies across various therapeutic areas. Committed to ethical standards and patient safety, the organization strives to accelerate the discovery of new treatments and improve patient outcomes while ensuring compliance with regulatory requirements. Through its expertise and strategic approach, Research Source aims to contribute significantly to the future of healthcare and the well-being of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials